BioHarvest Sciences Inc.
BHST
$7.69
$0.08811.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.00% | 11.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.00% | 11.30% | |||
| Cost of Revenue | 3.49% | 11.68% | |||
| Gross Profit | 11.45% | 11.01% | |||
| SG&A Expenses | 14.87% | -2.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.85% | 3.75% | |||
| Operating Income | -1.90% | 19.74% | |||
| Income Before Tax | 21.98% | -9.63% | |||
| Income Tax Expenses | 375.00% | -- | |||
| Earnings from Continuing Operations | 20.91% | -9.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.91% | -9.93% | |||
| EBIT | -1.90% | 19.74% | |||
| EBITDA | 16.15% | 10.09% | |||
| EPS Basic | 20.88% | -9.93% | |||
| Normalized Basic EPS | 21.92% | -9.70% | |||
| EPS Diluted | 20.88% | -9.93% | |||
| Normalized Diluted EPS | 21.92% | -9.70% | |||
| Average Basic Shares Outstanding | -0.05% | -0.03% | |||
| Average Diluted Shares Outstanding | -0.05% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||